Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23654686 | 0.84 | MEN1 (0.44) | GPR55 | |
| SCHEMBL23655124 | 0.83 | SLC22A12 (0.46) | GPR55GABRA1GABRG2GABRB3 | |
| SCHEMBL29111442 | 0.82 | GPR55 (0.44) | GPR55 | |
| SCHEMBL28573904 | 0.81 | GPR55 (0.42) | GPR55GABRA1GABRG2GABRB3 | |
| SCHEMBL24914351 | 0.81 | CYP1A2 (0.43) | GPR55GABRG2GABRB3 | |
| SCHEMBL7604074 | 0.81 | WDR5 (0.46) | GABRA1GABRG2GABRB3 | |
| SCHEMBL24914291 | 0.80 | CYP2A6 (0.43) | GPR55 | |
| SCHEMBL7600324 | 0.79 | WDR5 (0.44) | GABRA1GABRG2GABRB3 | |
| SCHEMBL6681906 | 0.79 | HPGDS (0.45) | GABRA1GABRG2GABRB3 | |
| SCHEMBL7931301 | 0.79 | TDP1 (0.41) | GABRA1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170143763-A1 | ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE | KUREHA CORPORATION (JP) | 2017-05-25 | — | — | US | disclosed |
| US-20160000827-A1 | ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE | KUREHA CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20150374743-A1 | ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE | KUREHA CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| EP-2959905-A1 | ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE | Kureha Corporation (JP) | 2015-12-30 | — | — | EP | disclosed |
| EP-2959906-A1 | ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE | Kureha Corporation (JP) | 2015-12-30 | — | — | EP | disclosed |